Health comorbidities and cognition in 1948 patients with idiopathic Parkinson's disease

被引:30
|
作者
Jones, J. D. [1 ,3 ]
Malaty, I. [2 ,3 ]
Price, C. C. [1 ,3 ]
Okun, M. S. [2 ,3 ]
Bowers, D. [1 ,2 ,3 ]
机构
[1] Univ Florida, McKnight Brain Inst, Dept Clin & Hlth Psychol, Gainesville, FL 32601 USA
[2] Univ Florida, McKnight Brain Inst, Dept Neurol, Gainesville, FL 32601 USA
[3] Univ Florida, McKnight Brain Inst, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32601 USA
关键词
Parkinson's disease/Parkinsonism; Neuropsychology; Cardiovascular; Comorbidities; Prevalence; WHITE-MATTER HYPERINTENSITIES; RISK-FACTORS; DEMENTIA; IMPAIRMENT; BRAIN; AGE; HYPERTENSION; INCIDENT; IMPACT;
D O I
10.1016/j.parkreldis.2012.06.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Health comorbidities, particularly cardiovascular factors, are well known to pose risks for cognitive decline in older adults. This study examined the prevalence and contribution of comorbidities on cognitive performance in a large cohort of Parkinson patients. Methods: Data on 1948 PD patients were obtained from the National Parkinson Foundation Quality Improvement Initiative (NPF-QII) registry, a multi-site initiative from NPF Centers of Excellence. Available comorbidity data included six common conditions (heart/circulation problems, diabetes, arthritis, cancer, respiratory disease, and other neurologic disease) that were clinician-rated for presence and severity. Available cognitive measures included semantic fluency and a 5-word recall memory task. The unique effects of comorbidities on cognition were analyzed (multiple hierarchical regression) controlling for demographic, PD disease severity (duration, Hoehn-Yahr), and medication status. Results: The two most reported comorbidities were arthritis (46.6%) and heart/circulation problems (36.3%), with diabetes affecting 9% of the sample. Severity of heart/circulation problems independently contributed to worse delayed recall performance (p = 0.03). A trend emerged for more severe diabetes as contributing to worse semantic fluency scores (p = 0.06). Conclusions: This study with a large cohort of PD patients provides evidence for a small detrimental influence of specific health comorbidities, particularly heart/circulatory and diabetes, on general measures of cognition. This effect is present, above and beyond the influences of basic demographic information (age), duration and staging of PD, and medication status. Future studies involving more refined cognitive indices and direct assessment of comorbidities are warranted. (c) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1073 / 1078
页数:6
相关论文
共 50 条
  • [1] Cognition and connectomes in nondementia idiopathic Parkinson's disease
    Colon-Perez, Luis M.
    Tanner, Jared J.
    Couret, Michelle
    Goicochea, Shelby
    Mareci, Thomas H.
    Price, Catherine C.
    NETWORK NEUROSCIENCE, 2018, 2 (01): : 106 - 124
  • [2] Genetic Influences on Cognition in Idiopathic Parkinson's Disease
    Amer, Hanan
    Shehata, Hatem
    Rashed, Laila Ahmed
    Helmy, Hanan
    El-Jaafary, Shaim
    Sabbah, Asmaa
    Ibrahim, Wael
    NEUROLOGY RESEARCH INTERNATIONAL, 2018, 2018
  • [3] Influence of levodopa on cognition of idiopathic Parkinson's disease
    Alonso-Prieto, E
    Michel-Esteban, E
    Trujillo-Matienzo, C
    Palmero-Soler, E
    NEUROLOGIA, 2004, 19 (10): : 710 - 718
  • [4] Associations between neuropsychiatric symptoms and cognition in Chinese idiopathic Parkinson's disease patients
    Guo, Xiaoyan
    Song, Wei
    Chen, Ke
    Chen, XuePing
    Zheng, Zhenzhen
    Cao, Bei
    Huang, Rui
    Zhao, Bi
    Wu, Ying
    Shang, Hui-Fang
    JOURNAL OF CLINICAL NEUROSCIENCE, 2015, 22 (03) : 578 - 582
  • [5] The Association between Cognition and Balance in idiopathic Parkinson's Disease
    Jung, S. H.
    King, L.
    Mancini, M.
    Carlson-Kuhta, P.
    Morris, R.
    Nutt, J.
    Horak, F.
    MOVEMENT DISORDERS, 2019, 34 : S692 - S693
  • [6] Vascular Risk Factors and Cognition in Idiopathic Parkinson's Disease
    Doiron, Maxime
    Simard, Martine
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2012, 24 (02) : 19 - 19
  • [7] Impact of Comorbidities on the Burden for Patients with Parkinson's Disease
    Ward, Alex
    Michels, Shannon L.
    Lanes, Stephan
    Gilmore, O'Neill N.
    Spyros, Papapetropoulos
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2010, 19 : S254 - S254
  • [8] Hemodynamics in patients with idiopathic Parkinson's disease
    Baik, J.
    Ma, H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E256 - E256
  • [9] Diabetes in patients with idiopathic Parkinson's Disease
    Becker, Claudia
    Brobert, Gunnar P.
    Johansson, Saga
    Jick, Susan S.
    Meier, Christoph R.
    DIABETES CARE, 2008, 31 (09) : 1808 - 1812
  • [10] Therapy for patients with idiopathic Parkinson's disease
    Reichmann, H
    Becker, A
    Fuchs, GA
    Lachenmeyer, L
    Müller, D
    Müngersdorf, M
    Schwarz, M
    AKTUELLE NEUROLOGIE, 2001, 28 : S253 - S255